WuXi Biologics (HKG:2269) said its substantial shareholder WuXi Biologics Holdings was looking to sell shares of the company, according to a Hong Kong bourse filing Friday.
The firm plans to sell 150 million existing shares representing 3.63% of the business at HK$38.52 apiece.
The transaction will decrease WuXi Biologics Holdings' stake in the company from 12.12% to 8.49%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments